BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report)’s stock price fell 3.8% during mid-day trading on Wednesday . The company traded as low as $1.46 and last traded at $1.49. 43,621 shares traded hands during trading, an increase of 23% from the average session volume of 35,439 shares. The stock had previously closed at $1.55.
BeyondSpring Stock Performance
The firm has a 50-day simple moving average of $1.71 and a 200 day simple moving average of $1.87.
About BeyondSpring
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Recommended Stories
- Five stocks we like better than BeyondSpring
- What Do S&P 500 Stocks Tell Investors About the Market?
- Energy Transfer: Powering Data With Dividends and Diversification
- Best Stocks Under $10.00
- Qualcomm Stock Is Coiling for a Breakout
- Short Selling – The Pros and Cons
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
